(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday.

The Laken Riley Act was approved by the Republican-held House last year, but was not taken up at the time in the Democratic-controlled Senate. It passed with bipartisan support on Wednesday only ...

Clash of the Handouts as Modi's BJP Seeks to Reclaim Delhi After Decades By Krishna N. Das and Aftab Ahmed NEW DELHI (Reuters) - Having unexpectedly won two Indian state votes late last year ...

NEW DELHI, Jan 22 (Reuters) - Having unexpectedly won two Indian state votes late last year, in big part due to a slew of handouts, Prime Minister Narendra Modi's party is deploying the same ...

Wonder Land: Donald Trump used to be accused of breaking norms. Now it’s ‘disruption.’ Question is: will this approach work in 2025? The answer doesn’t break easily into yes or no. Photo ...

The vote for final passage of the Laken Riley Act was 64-35, with 12 Democrats joining Republicans to approve it. The bill, which was amended in the Senate last week, will be sent back for another ...

The Senate voted Friday to advance the Laken Riley Act, putting Republicans a step closer to sending the first bill of the 119th Congress to President-elect Trump for his signature next week and ...

Wright said. It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session ...